Netris Pharma SAS

Where the EU money came from

Funding by EU programme. Amounts are Netris Pharma SAS's own share of each project, not the project's full budget.

Projects

4 EU-funded projects, newest first. Netris Pharma SAS led 2 of them as coordinator. Each links to the official record.

• NeckNETCoordinator

  INHIBITING RESISTANCE TO IMMUNOTHERAPY IN HEAD&NECK CANCER BY TARGETING NETRIN-1

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €4.7Mtheir share
• BonePainIIIAssociated partner

  Identifying mechanisms and novel treatments of bone pain – closing the gap to the clinic.

  Horizon Europe · 2024–2027 · Project on CORDIS ↗
• ImmunoNetCoordinator

  Inhibiting resistance to immunotherapy in Oncology by targeting Netrin-1

  Horizon Europe · 2022–2025 · Project on CORDIS ↗

  €2.5Mtheir share
• HERMIONE-2MANPartner

  First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

  €2.0Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• Kobenhavns UniversitetDenmark · 1 shared project
• Aarhus UniversitetDenmark · 1 shared project
• Karolinska InstitutetSweden · 1 shared project
• Tel Aviv UniversityIsrael · 1 shared project
• Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
• Universite Libre de BruxellesBelgium · 1 shared project
• Oulun YliopistoFinland · 1 shared project
• Universidade do PortoPortugal · 1 shared project
• I3s - Instituto de Investigacao e Inovacao Em Saude da Universidade do PortoPortugal · 1 shared project
• Region SyddanmarkDenmark · 1 shared project
• Organisation Europeenne Pour la Recherche et le Traitement du Cancer AISBLBelgium · 1 shared project
• Centre de Lutte Contre le Cancer Leon BerardFrance · 1 shared project
• Polymun Scientific Immunbiologische Forschung GmbHAustria · 1 shared project
• Astrazeneca UK LimitedUnited Kingdom · 1 shared project
• Nordic Bioscience A/SDenmark · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• drug discovery
• head and neck cancer
• immunotherapy
• oncology
• squamous cell carcinoma
• toxicology